06 Apr 2018
LIBERUM: Shield Therapeutics* - Positive outcome from FDA meeting; US Feraccru filing now planned 'as soon as possible' this year
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LIBERUM: Shield Therapeutics* - Positive outcome from FDA meeting; US Feraccru filing now planned 'as soon as possible' this year
Shield Therapeutics Plc (STX:LON) | 1.3 0 (-7.0%) | Mkt Cap: 10.4m
- Published:
06 Apr 2018 -
Author:
Roger Franklin | Graham Doyle -
Pages:
3